bacteria-3662695_960_720

Drop in prescriptions for antibiotic leads to fewer cases of superbug in Wales

pharmafile | August 20, 2019 | News story | Manufacturing and Production |  AMR, Antibiotics, C difficile, C. difficile, pharma, superbug 

Cuts to the number of prescriptions for antibiotics have led to a drop in the number of cases of the superbug C. difficile, an NHS health board has said.

The Betsi Cadwaladr health board, the largest health organisation in Wales, said prescriptions for antibiotics fell by 12.6 from 2017-2018 to 2018-2019. Wales hope to cut the number of antibiotic prescriptions by 5%.

The cutback saw the number of cases of C. difficile fall from 271 in 2017-18 to 166 cases in 2018-19.

Advertisement

Pauline Roberts, Betsi Cadwaladr’s primary care pharmacist, said: “Everyone understands we have a problem nationally with the overuse of antibiotics, but it’s hard to change without the tools to improve the way we deliver care.

“We’ve tried to work with GP practices to give them resources to support this work, and supporting them by educating patients that antibiotics don’t work against viruses.”  

The measures have seen far reaching cuts in prescriptions for antibiotics over the past few years.

Louis Goss

Related Content

Pharma sees climate disruption as growing supply-chain risk

Nine in ten pharmaceutical companies across the UK and G7 countries expect climate-related disruption to …

AI in pharma: From lab development to patient impact

In the decade to 2025, AI use in vaccine development has increased markedly but is …

drug-trials

LGC Group opens $100M Organic Chemistry Synthesis Centre of Excellence

LGC Group, a life sciences company, has opened its new Organic Chemistry Synthesis Centre of …

The Gateway to Local Adoption Series

Latest content